Project Details
| Status | Active |
|---|---|
| Effective start/end date | 02/27/20 → … |
Phase I/II, randomized, observer-blind, dose-ranging (4 Log CCID50/dose; 5 Log CCID50/dose, 6 Log CCID50/dose), YF-VAX-controlled, multi-center study in 572 adults in USA
Project: Research